Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Neurology

Building a Foundation: What is Paroxysmal Hemicrania?

At a Glance

Paroxysmal hemicrania causes severe, one-sided headache attacks lasting 2 to 30 minutes and occurring many times a day. A supervised indomethacin trial that completely stops the attacks is the key diagnostic clue, while imaging may rule out other causes.

If you have spent years searching for an answer to intense, stabbing head pain that strikes multiple times a day, finding the name Paroxysmal Hemicrania (PH) can bring immense emotional relief [1]. Many people with this condition wander through years of misdiagnoses—often being told they have migraines or “atypical” facial pain—before reaching a specialist who recognizes the pattern [2]. Understanding this condition is the first step toward the effective treatment that, for many, can offer substantial relief.

What is Paroxysmal Hemicrania?

Paroxysmal Hemicrania is a rare primary headache disorder. It belongs to a group of headaches known as Trigeminal Autonomic Cephalalgias (TACs) [2]. While the name sounds complicated, it describes three key things:

  • Trigeminal: The pain involves the trigeminal nerve, the main pathway for sensation in your face.
  • Autonomic: The headaches are accompanied by “automatic” physical reactions, like a tearing eye or a runny nose [2].
  • Cephalalgia: This is simply the medical term for head pain.

PH is characterized by very frequent, short-lived attacks of severe pain that stay on one side of the head during an attack [3]. Attacks typically last between 2 and 30 minutes and can happen anywhere from 5 to 40 times a day [2][4]. To meet formal diagnostic criteria, a person must experience at least 20 attacks overall.

How Rare is It?

PH is considered a rare condition, though exactly how rare is still being studied because it is so frequently missed.

  • Prevalence: Recent studies estimate that about 1.4 to 22 people out of every 100,000 have PH [5][6].
  • Demographics: While it can affect anyone, it is slightly more common in adult women than men [6].
  • Age of Onset: Most people begin experiencing symptoms in adulthood, often in their 30s [7]. However, it can occur in children as young as one year old, where it affects boys and girls almost equally [8].

The Biological Theory

The pain of PH is caused by a complex interaction in your brain’s wiring. Scientists believe it involves connections between three main areas:

  1. The Trigeminal Nerve: This nerve sends intense pain signals from around your eye and temple to your brain [2].
  2. The Hypothalamus: This is the brain’s “command center” for internal balance. Imaging studies often show activity in the posterior hypothalamus during an attack; researchers propose this area might help initiate the attacks or act as a “permissive” gate, though it is a proposed research mechanism rather than a proven diagnostic test [3][9].
  3. The Autonomic Reflex: When the pain signals fire, they trigger a reflex in the cranial parasympathetic system [10]. This is why, on the same side as the pain, you might experience:
    • Redness or tearing of the eye (the most common signs) [1].
    • A stuffy or runny nose [1].
    • Drooping of the eyelid or swelling [2].
    • A feeling of restlessness or the need to move around during the pain [11].

The “Indo-Test”: A Unique Diagnosis

The most remarkable feature of Paroxysmal Hemicrania—and what sets it apart from almost every other headache—is its “absolute” response to a specific anti-inflammatory medication called indomethacin [2][12].

In the medical world, a supervised trial is often called the Indo-test. According to international diagnostic standards (ICHD-3), a diagnosis of PH requires a complete response to a therapeutic dose of indomethacin [2]. This means the pain doesn’t just get a little better; it vanishes entirely when you are on the right dose [3]. If a patient only sees partial improvement, doctors will often look for a different diagnosis, such as Cluster Headache, which may look similar but does not respond to indomethacin in the same way [2][12]. An unsuccessful trial does not perfectly rule out PH, but it strongly suggests looking closely at the diagnosis.

Because PH can occasionally be mimicked by other underlying issues, doctors often recommend clinician-directed brain imaging, such as an MRI, to ensure the headaches are “primary” and not caused by another condition [13].

PH vs. Other Headaches

It is easy to confuse PH with other types of pain. Here is how they generally differ:

Feature Paroxysmal Hemicrania Cluster Headache SUNCT/SUNA Hemicrania Continua
Duration 2–30 minutes [2] 15–180 minutes [4] Seconds to a few minutes [14] Continuous [15]
Frequency 5–40 times per day [2] 1 every other day to 8 per day [4] Dozens to hundreds a day [16] Constant pain [15]
Indomethacin Absolute response [12] Usually no response [12] Usually no response Absolute response [17]

While PH and Hemicrania Continua both respond to indomethacin, Hemicrania Continua involves a constant, background ache that never goes away, whereas PH attacks have clear start and end points with total relief in between [15].

Common questions in this guide

What is paroxysmal hemicrania?
Paroxysmal hemicrania is a rare headache disorder. It causes severe pain on one side of the head in attacks that usually last 2 to 30 minutes and may occur 5 to 40 times a day. Tearing, eye redness, a stuffy or runny nose, eyelid drooping, or restlessness may occur on the painful side.
How is paroxysmal hemicrania diagnosed?
Doctors diagnose paroxysmal hemicrania mainly by the pattern of attacks and a supervised trial of indomethacin. The defining clue is complete disappearance of the attacks at an appropriate dose, rather than only partial relief. Formal diagnostic criteria also include at least 20 attacks, and brain imaging such as an MRI may be recommended to check for another cause.
What does a complete response to indomethacin mean?
A complete response means the paroxysmal hemicrania attacks stop entirely while you take the prescribed therapeutic dose; a small improvement is not the same result. If the trial does not work, paroxysmal hemicrania is not perfectly ruled out, but the clinician should reassess the dose, diagnosis, and other possible causes.
How is paroxysmal hemicrania different from cluster headache?
Both can cause severe one-sided pain and eye or nose symptoms, but their attack patterns differ. Paroxysmal hemicrania usually lasts 2 to 30 minutes and can occur 5 to 40 times a day, while cluster attacks last 15 to 180 minutes and usually occur less often. Paroxysmal hemicrania responds completely to indomethacin, whereas cluster headache usually does not.
Why might someone with paroxysmal hemicrania need an MRI?
An MRI is often considered because headaches that resemble paroxysmal hemicrania can occasionally be caused by another condition. Clinician-directed brain imaging helps determine whether the headaches are a primary disorder or are related to an underlying problem. Whether you need imaging depends on your history and neurologist's assessment.
What symptoms occur during a paroxysmal hemicrania attack?
During an attack, pain remains on one side and may be accompanied by tearing or redness of the eye, a blocked or runny nose, eyelid drooping, or facial swelling on that side. Many people also feel restless or need to move around. Keeping track of these features can help a clinician compare paroxysmal hemicrania with other headache disorders.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Paroxysmal hemicrania.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the specific dose of indomethacin I should start with, and how will we know if it is a 'complete' response?
  2. 2.Are there side effects I should watch for while taking indomethacin, and how can I protect my stomach?
  3. 3.Do my symptoms align more with Paroxysmal Hemicrania or another headache type like Cluster Headache?
  4. 4.Should I have an MRI to look for other possible causes for these headaches?
  5. 5.If my pain is not completely relieved by indomethacin, what are the next steps for my diagnosis?

References

References (17)
  1. 1

    Epidemiology and clinical features of paroxysmal hemicrania: A systematic review and meta-analysis.

    Henningsen MJ, Larsen JG, Karlsson WK, et al.

    Headache 2024; (64(1)):5-15 doi:10.1111/head.14658.

    PMID: 38205903
  2. 2

    Paroxysmal Hemicrania: An Update.

    Paliwal VK, Uniyal R

    Neurology India 2021; (69(Supplement)):S135-S143 doi:10.4103/0028-3886.315982.

    PMID: 34003159
  3. 3

    Paroxysmal Hemicrania.

    Osman C, Bahra A

    Annals of Indian Academy of Neurology 2018; (21(Suppl 1)):S16-S22 doi:10.4103/aian.AIAN_317_17.

    PMID: 29720814
  4. 4

    Trigeminal Autonomic Cephalalgias in Children and Adolescents: Cluster Headache and Related Conditions.

    Mack KJ, Goadsby P

    Seminars in pediatric neurology 2016; (23(1)):23-6.

    PMID: 27017018
  5. 5

    One-year prevalence of cluster headache, hemicrania continua, paroxysmal hemicrania and SUNCT in Norway: a population-based nationwide registry study.

    Hagen K

    The journal of headache and pain 2024; (25(1)):30 doi:10.1186/s10194-024-01738-x.

    PMID: 38443787
  6. 6

    Prevalence, demographics, comorbidities, and treatment patterns of patients with the trigeminal autonomic cephalalgias: a retrospective analysis of United States electronic health records.

    Moskatel LS, Ogunlaja O, Zhang N

    BMC neurology 2025; (25(1)):299 doi:10.1186/s12883-025-04314-1.

    PMID: 40691779
  7. 7

    Do paroxysmal hemicrania and hemicrania continua represent different headaches? A retrospective study.

    Paliwal VK, Uniyal R, Aneez A, Singh LS

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2019; (40(11)):2371-2376 doi:10.1007/s10072-019-03980-7.

    PMID: 31256266
  8. 8

    Paroxysmal hemicrania in children and adolescents: A systematic review.

    Bemanalizadeh M, Baghaei Oskouei H, Hadizadeh A, et al.

    Headache 2022; (62(8)):952-966 doi:10.1111/head.14354.

    PMID: 35833494
  9. 9

    Functional Neuroimaging in Trigeminal Autonomic Cephalalgias.

    Obermann M, Holle D, Nagel S

    Annals of Indian Academy of Neurology 2018; (21(Suppl 1)):S51-S56 doi:10.4103/aian.AIAN_357_17.

    PMID: 29720819
  10. 10

    Cluster headache and TACs: state of the art.

    Giani L, Proietti Cecchini A, Leone M

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2020; (41(Suppl 2)):367-375 doi:10.1007/s10072-020-04639-4.

    PMID: 32845489
  11. 11

    [Autonomic Disorders in Trigeminal Autonomic Cephalalgias: An Update].

    Kowa H

    Brain and nerve = Shinkei kenkyu no shinpo 2022; (74(3)):263-270 doi:10.11477/mf.1416202022.

    PMID: 35260525
  12. 12

    Cluster Headache and Other Trigeminal Autonomic Cephalalgias.

    Burish M

    Continuum (Minneapolis, Minn.) 2018; (24(4, Headache)):1137-1156 doi:10.1212/CON.0000000000000625.

    PMID: 30074553
  13. 13

    Indomethacin-Responsive Headache Disorders.

    Goadsby PJ

    Continuum (Minneapolis, Minn.) 2024; (30(2)):488-497 doi:10.1212/CON.0000000000001409.

    PMID: 38568495
  14. 14

    SUNCT and SUNA: An Update.

    Duggal AK, Chowdhury D

    Neurology India 2021; (69(Supplement)):S144-S159 doi:10.4103/0028-3886.315990.

    PMID: 34003160
  15. 15

    Overview of Trigeminal Autonomic Cephalalgias: Nosologic Evolution, Diagnosis, and Management.

    Wei DY, Yuan Ong JJ, Goadsby PJ

    Annals of Indian Academy of Neurology 2018; (21(Suppl 1)):S39-S44 doi:10.4103/aian.AIAN_348_17.

    PMID: 29720817
  16. 16

    SUNCT, SUNA and short-lasting unilateral neuralgiform headache attacks: Debates and an update.

    Kang MK, Cho SJ

    Cephalalgia : an international journal of headache 2024; (44(2)):3331024241232256 doi:10.1177/03331024241232256.

    PMID: 38415675
  17. 17

    Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment.

    Bahra A

    Cephalalgia : an international journal of headache 2023; (43(11)):3331024231214239 doi:10.1177/03331024231214239.

    PMID: 37950675

This page is for informational purposes only and does not constitute medical advice. A neurologist should confirm suspected paroxysmal hemicrania, guide imaging, and supervise any indomethacin trial.